Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

November 2014 - FRMC

Investigation of Canagliflozin Use in a Real-World Setting
11/14/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
In a new study, researchers investigated the demographic and clinical factors of patients initiating canagliflozin or DPP-4 therapy in a large commercially insured US population.
In a new study, researchers investigated the demographic and clinical factors of patients initiating canagliflozin or DPP-4 therapy in a large commercially insured US population.
In a new study, researchers...
11/14/2014
First Report Managed Care
Study Examines Cost-Effectiveness of Interferon for MS
11/14/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Clinical data from the EVIDENCE study found that the cost-effectiveness of subcutaneous interferon (IFN) ß-1a 44 mcg given 3 times weekly was favorable compared with intramuscular IFN ß-1a 30 mcg given once weekly for relapsing forms of...
Clinical data from the EVIDENCE study found that the cost-effectiveness of subcutaneous interferon (IFN) ß-1a 44 mcg given 3 times weekly was favorable compared with intramuscular IFN ß-1a 30 mcg given once weekly for relapsing forms of...
Clinical data from the EVIDENCE...
11/14/2014
First Report Managed Care
Examining Breakthrough Designation Labeling
11/14/2014

Kerri Fitzgerald

Kerri Fitzgerald
Breakthrough therapy designation was established as part of the FDA Safety and Innovation Act of 2012.
Breakthrough therapy designation was established as part of the FDA Safety and Innovation Act of 2012.
Breakthrough therapy designation...
11/14/2014
First Report Managed Care
Budget Model Analyzes Formulary Costs for Obesity Drugs
11/14/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
A recent study evaluated formulary cost implications associated with the addition of naltrexone/bupropion for the treatment of obesity in the United States.
A recent study evaluated formulary cost implications associated with the addition of naltrexone/bupropion for the treatment of obesity in the United States.
A recent study evaluated...
11/14/2014
First Report Managed Care
Tbo-Filgrastim Shows Significant Cost Saving for Payers
11/14/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
A pharmacy budget impact model to estimate, from a payer perspective, the impact of the introduction of tbo-filgrastim as an alternative short-acting granulocyte colony-stimulating factor on a pharmacy budget showed a total annual plan cost...
A pharmacy budget impact model to estimate, from a payer perspective, the impact of the introduction of tbo-filgrastim as an alternative short-acting granulocyte colony-stimulating factor on a pharmacy budget showed a total annual plan cost...
A pharmacy budget impact model...
11/14/2014
First Report Managed Care
More Generics, Biosimilars, and Orphan Drugs on the Horizon
11/14/2014

Jill Sederstrom

Jill Sederstrom
As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...
As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...
As patented products expire,...
11/14/2014
First Report Managed Care
Tools to Help Payers Manage Growing Drug Costs
11/14/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
As with other specialty drugs, the high cost of medications to treat hepatitis C presents payers with the challenge of helping their members get the medications they need, while attempting to maintain healthcare costs.
As with other specialty drugs, the high cost of medications to treat hepatitis C presents payers with the challenge of helping their members get the medications they need, while attempting to maintain healthcare costs.
As with other specialty drugs,...
11/14/2014
First Report Managed Care

News

News
Study Examines Costs for Various Psoriasis Treatments
11/14/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
The economic burden of psoriasis in the United States is significant, as it is estimated to cost $11.25 billion annually in total direct and indirect healthcare costs, according to statistics from the National Psoriasis Foundation.
The economic burden of psoriasis in the United States is significant, as it is estimated to cost $11.25 billion annually in total direct and indirect healthcare costs, according to statistics from the National Psoriasis Foundation.
The economic burden of psoriasis...
11/14/2014
First Report Managed Care

Department

Conference Insider
AMCP Addresses Stance on Federal and State Legislative and Regulatory Moves
11/14/2014

Jill Sederstrom

Jill Sederstrom
Legislation on medication therapy management expansion and Medicare drug price negotiations are being discussed on the federal level, while states are considering legislation in the areas of biosimilars, controlled substances, and benefit...
Legislation on medication therapy management expansion and Medicare drug price negotiations are being discussed on the federal level, while states are considering legislation in the areas of biosimilars, controlled substances, and benefit...
Legislation on medication...
11/14/2014
First Report Managed Care
Conference Insider
Paradigm Change: New Guidelines on Managing Cholesterol
11/14/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
“This is a large paradigm change for clinicians,” said Joseph Saseen, PharmD, professor, vice chair, department of clinical pharmacy, professor, department of family medicine, University of Colorado Skaggs School of Pharmacy and...
“This is a large paradigm change for clinicians,” said Joseph Saseen, PharmD, professor, vice chair, department of clinical pharmacy, professor, department of family medicine, University of Colorado Skaggs School of Pharmacy and...
“This is a large paradigm change...
11/14/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Abuse and Misuse of Opioid Medications
09/19/2013

Tim Casey

Tim Casey
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been...
09/19/2013
First Report Managed Care
News
Melanoma Drugs Show Some Success
06/21/2011
06/21/2011
First Report Managed Care
News
Changes in Appearance of Medicine Effects Patient Adherence
07/15/2014
A recent study found that individuals are more likely to stop taking their medication after a heart attack if the appearance of their medication changes without explanation [Ann Intern Med. 2014;161(2):96-103]. Aaron S. Kesselheim, MD, JD,...
A recent study found that individuals are more likely to stop taking their medication after a heart attack if the appearance of their medication changes without explanation [Ann Intern Med. 2014;161(2):96-103]. Aaron S. Kesselheim, MD, JD,...
A recent study found that...
07/15/2014
First Report Managed Care
News
New FDA Commissioner Confirmed by Senate
05/10/2017
On Tuesday, the US Senate confirmed Scott Gottlieb, MD, to head the US Food and Drug Administration.
On Tuesday, the US Senate confirmed Scott Gottlieb, MD, to head the US Food and Drug Administration.
On Tuesday, the US Senate...
05/10/2017
First Report Managed Care
Asaf Kleinbort, CEO and co-founder of Medorion
Commentary
Behavior Focused Care: The Next Frontier
08/11/2021

Asaf Kleinbort, CEO and cofounder, Medorion

Asaf Kleinbort, CEO and cofounder, Me...
“The next frontier in public health will be scalable personalized communication, and it will seismically change the interactions between payer, provider, and health care recipient,” says Asaf Kleinbort, CEO and cofounder, Medorion.
“The next frontier in public health will be scalable personalized communication, and it will seismically change the interactions between payer, provider, and health care recipient,” says Asaf Kleinbort, CEO and cofounder, Medorion.
“The next frontier in public...
08/11/2021
Integrated Healthcare Executive

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

November 2014 Volume 11 Issue 11

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement